Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Merck Sharp & Dohme Corp. v. Wyeth LLC
Case Number:
Case Type:
IPR
Status:
Final Written Decision
Petitioner:
Merck Sharp & Dohme Corp.
Patent Owner:
Wyeth LLC
Tech Center:
1600
-
November 06, 2020
PTAB Again Upholds Pfizer Pneumonia Vaccine Patent Claim
In a pair of decisions on remand from the Federal Circuit, the Patent Trial and Appeal Board has upheld a claim in a patent covering Pfizer's blockbuster Prevnar 13 pneumonia vaccine, determining for the second time that Merck failed to show it was invalid as obvious.
-
June 14, 2017
Merck Wins PTAB Review Of Pfizer Pneumonia Vax Patent
The Patent Trial and Appeal Board agreed Tuesday to review a patent related to Pfizer Inc.'s top-selling Prevnar 13 pneumonia vaccine, finding Merck Sharp & Dohme Corp. showed the patent was likely invalid.